TG Therapeutics Inc. (TGTX): Share Price, Stock Analysis, Annual Report | Value Research Get TG Therapeutics Inc. (TGTX)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Biotechnology & Pharma Research

TG Therapeutics Inc. (TGTX)

NASDAQ: TGTX

  • Market Capitalisation info

    $1,220 Mln


  • 12 Month Earnings info

    $-322 Mln

  • Price to Earnings info

    --

$7.90

As on 16-Aug-2022 13:44 EDT

up-down-arrow $-0.51-6.01%

  • Prev Close info

    $8.40

  • Day's Openinfo

    $8.43

  • Today's Highinfo

    $8.43

  • Today's Lowinfo

    $7.74

  • Today's Volumeinfo

    1,268,999

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
TG Therapeutics (TGTX)
-58.45 27.34 21.46 -65.36 6.42 -7.00 10.16
S&P BSE Sensex
2.73 11.31 13.35 7.95 17.05 13.73 12.94
S&P Small-Cap 600
-7.09 14.53 9.50 -3.52 13.13 9.30 11.14
As on 16-Aug-2022
2021
2020
2019
2018
2017
2016
2015
TG Therapeutics (TGTX)
-63.48 368.65 170.73 -49.81 76.34 -61.02 -24.68
S&P Small-Cap 600
25.27 9.57 20.86 -9.70 11.73 24.74 -3.36
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        Chairman, CEO & Pres

        Mr. Michael S. Weiss Esq.

        CFO, Corp. Sec. & Treasurer

        Mr. Sean A. Power CPA, CPA

        Headquarters

        New York, NY
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $1,220.30 Mln

        • Revenue (TTM) info

          $7.91 Mln

        • Earnings (TTM) info

          $-321.68 Mln

        • Cash info

          $233.20 Mln

        • Total Debt info

          $79.06 Mln

        • Insider's Holding

          8.31%

        • Liquidity info

          Low

        • 52 Week range info

          $3.48 - 35.94

        • Shares outstanding info

          144,435,008

        • 10 Years Aggregate:

          CFO: $-1,022.99 Mln

          EBITDA: $-1,309.14 Mln

          Net Profit: $-1,327.84 Mln

        About The Company

        • Business

          TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

        • IPO Date

          14-Dec-1995

        • Chairman, CEO & Pres

          Mr. Michael S. Weiss Esq.

        • CFO, Corp. Sec. & Treasurer

          Mr. Sean A. Power CPA, CPA

        • Listing info

          NASDAQ: TGTX

        • Country

          United States

        • Headquarters info

          New York, NY

        • Website info

          https://www.tgtherapeutics.com